Markus Jerling

Fluvoxamine Inhibition and Carbamazepine Induction of the Metabolism of Clozapine

Markus Jerling, Leif Lindström, Ulf Bondesson et al. · Therapeutic Drug Monitoring · 1994 · 279 citations

Drug Interactions, Caffeine Test, Psychoactive Drug +13

A phase I dose-escalation study of IMAB362 (Zolbetuximab) in patients with advanced gastric and gastro-oesophageal junction cancer

Uğur Şahin, Martin Schüler, Heike Richly et al. · European Journal of Cancer · 2018 · 155 citations · Full text

Safety and tolerability of intracerebroventricular PDGF-BB in Parkinson’s disease patients

Gesine Paul, Olof Zachrisson, Andrea Varrone et al. · Journal of Clinical Investigation · 2015 · 104 citations · Full text

Clinical Neurology, Clinical Neuroscience, Pharmacotherapy +18

The CYP2D6 genotype predicts the oral clearance of the neuroleptic agents perphenazine and zuclopenthixol*

Markus Jerling, Marja-Liisa Dahl, Anna Åberg-Wistedt et al. · Clinical Pharmacology & Therapeutics · 1996 · 100 citations

Studies to Investigate the Pharmacokinetic Interactions Between Ranolazine and Ketoconazole, Diltiazem, or Simvastatin During Combined Administration in Healthy Subjects

Markus Jerling, Bee‐Lian Huan, Kwan Leung et al. · The Journal of Clinical Pharmacology · 2005 · 88 citations

Healthy Subjects, Pharmacotherapy, Experimental Pharmacology +21